Tier 4 — mechanistic
High plasma levels of betaine, a trimethylamine N-Oxide-related metabolite, are associated with the severity of cirrhosis
Liver international : official journal of the International Association for the Study of the Liver
2023
43(2):424-433
Bibliography
- PubMed
- PMID 35585781
- PubMed Central
- PMC10084422
- Funding
- Funding was not specified in the indexed record or accessible funding metadata.
- Competing interests
- Reported disclosure: EG and MAC are employees of Labcorp, carried out the NMR measurements, and assisted with the interpretation of the data. Labcorp was not involved in the study design, data analysis, nor the decision to publish the results. VM reports a VENI research grant by the Netherlands Organization for Scientific Research (NWO; grant #09150161810030), a Research grant from the Dutch Ministry of Economic Affairs (Health~Holland Public Private Partnership grant #PPP‐2019‐024), and a Research grant from the Dutch Society for Gastroenterology (NVGE; #01–2021), all outside the submitted work. All other authors declare no conflicts of interest.
Study snapshot
| Design | Cohort biomarker comparison |
|---|---|
| Model | Human participants |
| Sample | 129 cirrhotic patients versus 4837 population participants; 13 transplant follow-ups |
| Intervention | Measured betaine status and related metabolites; no randomized TMG treatment |
| Duration | Disease assessment and transplant follow-up |
| Endpoints | Cirrhosis severity; Transplantation |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified



